Drug safety alert: Adverse reactions linked to Colistimethate Sodium flagged by Indian Pharmacopoeia Commission - Video

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that Colistimethate Sodium, an antibiotic indicated for the treatment of infections caused by susceptible strains of certain gram-negative bacilli is linked with adverse drug reactions (ADRs) named Bartter's like Syndrome.

This came after a preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.

Colistimethate is an antibiotic indicated for the treatment of infections caused by susceptible strains of certain gram-negative bacilli. It is particularly useful for targeting sensitive strains of Pseudomonas aeruginosa.

For more details check out the link given below:

Drug Safety Alert: Indian Pharmacopoeia Commission Flags Adverse Reactions Linked To Colistimethate Sodium